Advertisement

Topics

Latest "Ganaxolone Phase Data Supports Progressing Phase Patients With" News Stories

13:43 EST 10th December 2018 | BioPortfolio

Here are the most relevant search results for "Ganaxolone Phase Data Supports Progressing Phase Patients With" found in our extensive news archives from over 250 global news sources.

More Information about Ganaxolone Phase Data Supports Progressing Phase Patients With on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Ganaxolone Phase Data Supports Progressing Phase Patients With for you to read. Along with our medical data and news we also list Ganaxolone Phase Data Supports Progressing Phase Patients With Clinical Trials, which are updated daily. BioPortfolio also has a large database of Ganaxolone Phase Data Supports Progressing Phase Patients With Companies for you to search.

Showing "Ganaxolone Phase Data Supports Progressing Phase Patients With" News Articles 1–25 of 47,000+

Monday 10th December 2018

Providence Health System to Continue Providing Emergency Services Through April 30, 2019

Reflecting its continued commitment to the residents of the District of Columbia, Providence Health System will operate its Emergency Care Center with necessary support services through the current flu season. The Emergency Care Center will remain open through April 30, 2019 and supported by services needed for emergency care, including lab, diagnostic ima...


Hologic Inc HOLX Medical Equipment Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250

SummaryHologic Inc Hologic develops, manufactures and supplies diagnostic products, medical imaging systems, surgical products and lightbased aesthetic and medical treatment systems. The company offers products to aid in the diagnosis of human diseases; breast imaging and related products and accessories; gynecology surgical products including endometrial ablation system and hysteroscopic tissue r...

Cumberland Managed Services Rated by KLAS in Partial IT Outsourcing

Cumberland announced today that its managed services offering has been fully rated by KLAS and boasts above market average scores in all key performance areas – value, relationship, product and operations. KLAS is the premier research organization for providers who want to receive honest, accurate feedback from peers on products and vendors. Cum...


Netsmart Announces Strategic Investment from TA Associates and GI Partners

Partnership Continues 50 Year Journey of Delivering Solutions for Human Services and Post-Acute Providers Netsmart, a healthcare technology provider that designs, builds and delivers a technology platform including electronic health record (EHR) solutions and services, announced it has completed a recapitalization representing a strategic minori...

Also on our list of notable advances this year is a study that showed how a new #genetherapy approach for beta-thalassemia patients reduced or eliminated the need for further transfusions: http://bit.ly/2PuwkIV  (Image courtesty Prof. Osaro Erhabor)pic.

Also on our list of notable advances this year is a study that showed how a new #genetherapy approach for beta-thalassemia patients reduced or eliminated the need for further transfusions: http://bit.ly/2PuwkIV  (Image courtesty Prof. Osaro Erhabor) pic.twitter.com/Wkqs1J57MR

Allergan’s Phase III Botox trial for depression pushed to H2 2019

Allergan’s Botox (onabotulinumtoxin A) Phase III trial in major depressive disorder (MDD) is slated to initiate in the second half of...Read More... The post Allergan’s Phase III Botox trial for depression pushed to H2 2019 appeared first on Pharmaceutical Technology.

France Crown and Bridge Procedures Outlook to 2025 [Report Updated: 01092018] Prices from USD $2546

France Crown and Bridge Procedures Outlook to 2025SummaryGlobalData's new report, France Crown and Bridge Procedures Outlook to 2025, provides key procedures data on the France Dental Crown and Bridge Procedures. The report provides procedure volumes within market segment Dental Crown and Bridge Procedures.The data in the report is derived from dynamic market forecast models. GlobalData uses epid...

Nivolumab Combo Shows Early Activity in Relapsed/Refractory AML

The combination of nivolumab and azacitidine demonstrated a favorable responses and overall survival in patients with relapsed/refractory acute myeloid leukemia.

Addressing Off-Target Effects of TKIs in Pediatric CML

Briana Patterson, MD, discusses the off-target effects of tyrosine kinase inhibitors in pediatric patients with chronic myeloid leukemia.

New Data from the AEROSURF® Phase 2b Clinical Program shows AEROSURF® Appears to Reduce Incidence and Severity of Bronchopulmonary Dysplasia in Preterm Infants with RDS

Windtree Therapeutics Inc. (OTCQB: WINT) today announced that data from the AEROSURF® phase 2 clinical program in premature infants with respiratory distress syndrome (RDS) was presented at the 2018 Hot Topics in Neonatology Annual Meeting (2018 Hot Topics) held December 2 - 5 in Washington D.C. The post New Data from the AEROSURF® Phase 2b Clinical Program shows AEROSURF® Appears to Reduce...

Annual flu vaccination reduces risk of death in patients with heart failure, study finds

The risk of all-cause and cardiovascular death in patients with heart failure is reduced by almost one fifth in those having annual flu vaccinations compared with non-vaccinated patients, a Danish...

Maria Sophocles, M.D. Provides 2019 Health Forecast

Trends to leave behind and a snapshot of new solutions for all over health As we head into 2019, Maria Sophocles, M.D., OB/GYN at Women’s Healthcare of Princeton, reminds us not to believe every trend a celebrity touts, and describes what’s new as well as tried and true solutions to recurring, embarrassing health issues and new technology to ...

OneLegacy to Provide “Living” Tissue to JRF Ortho

Transplantation of “Living” Cells in Knees, Ankles and Other Joints Will Allow More People to Walk and Improve Quality of Life OneLegacy, the nation’s largest organ, eye and tissue procurement organization, has expanded its reach of helping more people lead healthier lives through its new commitment to provide fresh, “living” cartilage to the...

LANDMARK DECISION ON ASR

In a landmark decision, the Union Health Ministry on November 29 this year approved a formula for determination of compensation for patients who had received faulty Articular Surface Replacement (ASR) hip implants manufactured by DePuy International Ltd, UK, a subsidiary of Johnson & Johnson (J&J).

Japan Crown and Bridge Procedures Outlook to 2025 [Report Updated: 01092018] Prices from USD $2546

Japan Crown and Bridge Procedures Outlook to 2025SummaryGlobalData's new report, Japan Crown and Bridge Procedures Outlook to 2025, provides key procedures data on the Japan Dental Crown and Bridge Procedures. The report provides procedure volumes within market segment Dental Crown and Bridge Procedures.The data in the report is derived from dynamic market forecast models. GlobalData uses epidemi...

Axonics® Announces Publication of NICE Briefing

The U.K.’s National Institute for Health and Care Excellence Published a Medtech Innovation Briefing on the Axonics r-SNM® System Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of...

FairJourney Biologics ‘Future-Proofs’ Therapeutic Antibody Discovery with Geneious Biologics

Geneious Biologics, an enterprise software solution for companies engaged in screening of antibodies and antibody-like molecules, has been selected by FairJourney Biologics, a leading contract research organization (CRO), to support the company’s growth as it incorporates increasingly large Sanger data sets and next-generation sequencing (NGS) into its d...

WuXi AppTec Expands Site in California for Pharmaceutical R&D Services

SAN DIEGO and SHANGHAI, Dec. 10, 2018 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company with global operations, announces the expansion of its facilities in San Diego, California. WuXi AppTec's newly expanded facility will establish a center of excellence in screening, discovery biology, pharmacology, and small m...

New Trends in Drug Safety and the Growing Role of Real-World Evidence

Instant download of paper http://bit.ly/DrugSafetyRWE A renewed focus on drug safety has emerged with the increased number of approved drugs, greater availability of information, and more direct involvement of patients in their treatments. Evidera’s latest paper covers the new trends regarding drug safety, and how Real-World Evidence is moving to the forefront. Key Topics: Shifts […] The p...

Synergy Pharmaceuticals Inc SGYP Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummarySynergy Pharmaceuticals Inc Synergy Pharma is a biopharmaceutical company that develops and commercializes new treatments for gastrointestinal GI diseases. The company pioneered its RD efforts to develop its proprietary uroguanylinbased GI platform. It is also developing analogs of uroguanylin, a naturally occurring human GI peptide that promotes normal bowel function. The company's portfol...

Dr. Breanna Koch Joins Aspen Dental in Acworth

Dr. Breanna Koch and Team Offer Full Service Dental Care and Personalized Treatment Plans Breanna Koch, D.D.S., has joined the Aspen Dental team at 3245 Cobb Parkway Northwest. Dr. Koch grew up in the Midwest and attended dental school in Nebraska where she earned her Doctor of Dental Surgery degree from Creight

Can Staging for Lung Cancer Better Guide Treatment Decisions?

Researchers found that patients with stage I/II lung cancer have relatively long-term survival when treated with chemoradiotherapy, calling into question the practice of combining these patients with stage III patients.

CStone Pharmaceuticals Appoints Former MSD Global Oncology Early Development Executive Director Archie Tse, M.D., Ph.D., as the newly established SVP, Chief Translation Medicine Officer

Dr. Tse's Extensive Track Record in Oncology Early Clinical Development Will Strengthen CStone's Core Competence as a Clinical Development Engine and Solidify CStone's Position Among Leading Innovative Biopharma Companies in China SUZHOU, China, Dec. 10, 2018 /PRNewswire/ -- CStone Pharmaceuticals, a biopharma company focused on developing and commercializing...

Pharmacy should take Brexit lead

As discussions continue over the relationship the UK will have with the EU, pharmacy bodies must do what they can to protect the interests of patients, whichever form of Brexit emerges.

Number of Physicians Applying for Obesity Medicine Certification Soars to Nearly 900

American Board of Obesity Medicine (ABOM) reports 22% increase in obesity medicine certification applications Interest in obesity medicine continues to rise as nearly 900 physicians apply for certification. That’s according to the American Board of Obesity Medicine (ABOM), which reports today that 890 physicians have applied to take the 2019 ABOM


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks